{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:20:44Z","timestamp":1784697644732,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/N\/NZ2\/02571"],"award-info":[{"award-number":["2017\/27\/N\/NZ2\/02571"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/00094"],"award-info":[{"award-number":["PI18\/00094"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["SAF2017-88126R"],"award-info":[{"award-number":["SAF2017-88126R"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["SAF2009-08460"],"award-info":[{"award-number":["SAF2009-08460"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["PID2019-106404RB-I00"],"award-info":[{"award-number":["PID2019-106404RB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT-1512\/22"],"award-info":[{"award-number":["IT-1512\/22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["KK-2019\/00049"],"award-info":[{"award-number":["KK-2019\/00049"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT-1211\/19"],"award-info":[{"award-number":["IT-1211\/19"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.molpha.2025.100075","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:35:39Z","timestamp":1758760539000},"page":"100075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-1772","authenticated-orcid":false,"given":"Patricia","family":"Miranda-Azpiazu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-5757","authenticated-orcid":false,"given":"Carolina","family":"Muguruza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-9192","authenticated-orcid":false,"given":"Tomasz Maciej","family":"Stepniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-4765","authenticated-orcid":false,"given":"Itziar","family":"Muneta-Arrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-0169","authenticated-orcid":false,"given":"David","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1979","authenticated-orcid":false,"given":"Jos\u00e9","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-012X","authenticated-orcid":false,"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-0863","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-3204","authenticated-orcid":false,"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-4449","authenticated-orcid":false,"given":"Jana","family":"Selent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-9825","authenticated-orcid":false,"given":"Rebeca","family":"Diez-Alarcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-6714","authenticated-orcid":false,"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2025.100075_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.molpha.2025.100075_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","article-title":"Structure and function of serotonin G protein-coupled receptors","volume":"150","author":"McCorvy","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.molpha.2025.100075_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molpha.2025.100075_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100059","article-title":"5-HT2A receptors: pharmacology and functional selectivity","volume":"77","author":"Cummins","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molpha.2025.100075_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100075_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100075_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41592-020-0884-y","article-title":"GPCRmd uncovers the dynamics of the 3D-GPCRome","volume":"17","author":"Rodr\u00edguez-Espigares","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.molpha.2025.100075_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74101","article-title":"Effector membrane translocation biosensors reveal G protein and \u03b2arrestin coupling profiles of 100 therapeutically relevant GPCRs","volume":"11","author":"Avet","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.molpha.2025.100075_bib9","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2025.100075_bib10","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41467-024-48196-2","article-title":"G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits","volume":"15","author":"Kossatz","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2025.100075_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adi4747","article-title":"Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling","volume":"17","author":"Wright","year":"2024","journal-title":"Sci Signal"},{"key":"10.1016\/j.molpha.2025.100075_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","article-title":"Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists","volume":"13","author":"Karaki","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.molpha.2025.100075_bib13","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","article-title":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics","volume":"28","author":"Jaster","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.molpha.2025.100075_bib14","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1017\/S1461145713000722","article-title":"Serotonergic hallucinogens as translational models relevant to schizophrenia","volume":"16","author":"Halberstadt","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cn300138m","article-title":"Animal models of serotonergic psychedelics","volume":"4","author":"Hanks","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100075_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molpha.2025.100075_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acs.chemrev.5b00561","article-title":"Theoretical aspects of GPCR-ligand complex pharmacology","volume":"117","author":"Kenakin","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.molpha.2025.100075_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0703311","article-title":"Inverse agonism at G protein coupled receptors: (patho)physiological relevance and implications for drug discovery","volume":"130","author":"de Ligt","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(02)01993-4","article-title":"Mechanisms of inverse agonism at G-protein-coupled receptors","volume":"23","author":"Strange","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molpha.2025.100075_bib20","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/acschemneuro.9b00302","article-title":"Big data challenges targeting proteins in GPCR signaling pathways; combining PTML-ChEMBL models and [35S]GTP\u03b3S binding assays","volume":"10","author":"Diez-Alarcia","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100075_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3565(24)29327-7","article-title":"5-hydroxytryptamine2A receptor inverse agonists as antipsychotics","volume":"299","author":"Weiner","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.molpha.2025.100075_bib22","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2174\/1381612821666150605111236","article-title":"Atypical antipsychotics and inverse agonism at 5-HT2 receptors","volume":"21","author":"Sullivan","year":"2015","journal-title":"Cur Pharm Design"},{"key":"10.1016\/j.molpha.2025.100075_bib23","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/s41380-024-02531-7","article-title":"Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor","volume":"29","author":"Gaitonde","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.molpha.2025.100075_bib24","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1111\/bph.16368","article-title":"Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain","volume":"182","author":"Muneta-Arrate","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.1995.tb14977.x","article-title":"The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors","volume":"115","author":"Bonhaus","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molpha.2025.100075_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0969-8051(99)00022-0","article-title":"Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent","volume":"26","author":"Tan","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.molpha.2025.100075_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01253052","article-title":"Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat","volume":"61","author":"Sietnieks","year":"1985","journal-title":"J Neural Transm"},{"key":"10.1016\/j.molpha.2025.100075_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(87)90175-0","article-title":"Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation","volume":"137","author":"Koenig","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants","volume":"26","author":"Becker","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.euroneuro.2012.10.006","article-title":"Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects","volume":"23","author":"Muguruza","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41398-021-01430-7","article-title":"Opposite alterations of 5-HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile","volume":"11","author":"Diez-Alarcia","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.molpha.2025.100075_bib34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ejhg.2012.249","article-title":"Spanish regulatory approach for biobanking","volume":"21","author":"Arias-Diaz","year":"2013","journal-title":"Eur J Hum Gen"},{"key":"10.1016\/j.molpha.2025.100075_bib35","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.euroneuro.2019.10.013","article-title":"Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: selective biased agonism via G\u03b1i1-proteins","volume":"29","author":"Garc\u00eda-Bea","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.euroneuro.2020.05.004","article-title":"Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for G\u03b1i1- and neutral antagonism for G\u03b1q\/11-proteins in human brain cortex","volume":"36","author":"Muneta-Arrate","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib37","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s43440-021-00253-z","article-title":"Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTP\u03b3S binding assays combined with immunoprecipitation","volume":"73","author":"Diez-Alarcia","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.molpha.2025.100075_bib39","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1523\/JNEUROSCI.14-11-07109.1994","article-title":"Modulation of Ca2+ channels by PTX-sensitive G-proteins is blocked by N-ethylmaleimide in rat sympathetic neurons","volume":"14","author":"Shapiro","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.molpha.2025.100075_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(99)00827-4","article-title":"Characterization of receptor-mediated [35S]GTP\u03b3S binding to cortical membranes from postmortem human brain","volume":"390","author":"Gonz\u00e1lez-Maeso","year":"2000","journal-title":"Eur J.Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1460-9568.2004.03505.x","article-title":"Mechanism of GABA receptor-mediated inhibition of spontaneous GABA release onto cerebellar Purkinje cells","volume":"20","author":"Harvey","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.molpha.2025.100075_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.119.118927","article-title":"New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology","volume":"97","author":"Michel","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib43","doi-asserted-by":"crossref","first-page":"D425","DOI":"10.1093\/nar\/gkae1065","article-title":"GPCRdb in 2025: adding odorant receptors, data mapper, structure similarity search and models of physiological ligand complexes","volume":"53","author":"Herrera","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molpha.2025.100075_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.molpha.2025.100075_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molpha.2025.100075_bib46","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: resources for positioning of proteins in membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molpha.2025.100075_bib47","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"key":"10.1016\/j.molpha.2025.100075_bib48","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/acschemneuro.0c00477","article-title":"Ligand with two modes of interaction with the dopamine D2 receptor\u2014an induced-fit mechanism of insurmountable antagonism","volume":"11","author":"\u00c5gren","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100075_bib49","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/ct9000685","article-title":"ACEMD: accelerating biomolecular dynamics in the microsecond time scale","volume":"5","author":"Harvey","year":"2009","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.molpha.2025.100075_bib50","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.molpha.2025.100075_bib51","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.molpha.2025.100075_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.molpha.2025.100075_bib53","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1021\/jp101759q","article-title":"Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types","volume":"114","author":"Klauda","year":"2010","journal-title":"J Phys Chem"},{"key":"10.1016\/j.molpha.2025.100075_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.molpha.2025.100075_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.111.183780","article-title":"Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo","volume":"339","author":"Yadav","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.molpha.2025.100075_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96736-3","article-title":"LSD-stimulated behaviors in mice require \u03b2-arrestin 2 but not \u03b2-arrestin 1","volume":"11","author":"Rodriguiz","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.molpha.2025.100075_bib57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100075_bib58","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-protein-coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100075_bib59","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100075_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.molpha.2025.100075_bib61","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","article-title":"A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor","volume":"255","author":"De Lean","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100075_bib62","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1471-4159.1984.tb05375.x","article-title":"Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors","volume":"43","author":"Battaglia","year":"1984","journal-title":"J Neurochem"},{"key":"10.1016\/j.molpha.2025.100075_bib63","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.neuron.2025.06.012","article-title":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics","volume":"113","author":"Jain","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100075_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)00775-0","article-title":"Pharmacological characterisation of human 5-HT2 receptor subtypes","volume":"414","author":"Jerman","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","article-title":"Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors","volume":"370","author":"Knight","year":"2004","journal-title":"Naunyn Schmiedeber's Arch Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0026-895X(25)13392-0","article-title":"Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles","volume":"33","author":"Darchen","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ddr.430130104","article-title":"Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5-HT2 receptors","volume":"13","author":"Dudley","year":"1988","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.molpha.2025.100075_bib68","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/mol.114.097022","article-title":"Detection of new biased agonists for the serotonin 5-HT2A receptor: modeling and experimental validation","volume":"87","author":"Mart\u00ed-Solano","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/mol.110.068106","article-title":"Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor","volume":"79","author":"Tschammer","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100075_bib70","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41589-018-0145-x","article-title":"Structural insights into binding specificity, efficacy and bias of a \u03b22AR partial agonist","volume":"14","author":"Masureel","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molpha.2025.100075_bib71","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1039\/D1SC00749A","article-title":"Mechanistic insights into dopaminergic and serotonergic neurotransmission - concerted interactions with helices 5 and 6 drive the functional outcome","volume":"12","author":"Stepniewski","year":"2021","journal-title":"Chem Sci"},{"key":"10.1016\/j.molpha.2025.100075_bib72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100075_bib73","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1232807","article-title":"Structural basis for molecular recognition at serotonin receptors","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100075_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25156356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25156356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:14:19Z","timestamp":1763979259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25156356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0026895X25156356"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100075","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100075"}}